Please use this identifier to cite or link to this item:
Title: Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity
Authors: Cimini, Flavia Agata
Barchetta, Ilaria
Ceccarelli, Valentina
Chiappetta, Caterina
Di Biasio, Alberto
Bertoccini, Laura
Sentinelli, Federica
Leonetti, Frida
Silecchia, Gianfranco
Di Cristofano, Claudio
Baroni, Marco Giorgio
Velotti, Francesca Romana 
Cavallo, Maria Gisella
Issue Date: 2020
Granzyme B (GrB) is a serine protease produced by immune and non-immune cells, able to promote multiple processes, like apoptosis, inflammation, extracellular matrix remodeling and fibrosis. GrB expression in visceral adipose tissue (VAT) was associated with tissue damage, local inflammation and insulin resistance in obesity murine model, but there is no data in humans. Aim of this study was to explore the expression of GrB in VAT from obese subjects in relation to adipose tissue injury, inflammation, metabolic alterations and GrB circulating levels. For this purpose, 85 obese individuals undergoing bariatric surgery and 35 healthy subjects (as control) were recruited at Sapienza University, Rome, Italy. Study participants underwent clinical work-up and routine biochemistry. mRNA expression of GrB in VAT and of a panel of VAT inflammatory markers was analyzed by real-time PCR. Serum GrB levels were measured by Elisa Affymetrix EBIO. We observed that 80% of obese patients expressed GrB mRNA in VAT, and GrB VAT expression was associated with the presence of local inflammation and glucose homeostasis alterations. Moreover, GrB serum levels, which were higher in obese subjects compared to non-obese healthy individuals, were associated with GrB expression in VAT and glyco-metabolic impairment. Our data show, for the first time in humans, that obese subjects with "sick" fat and altered glucose tolerance exhibit GrB expression in VAT, and suggest that GrB might contribute to obesity-related VAT inflammatory remodeling and glucose homeostasis dysregulation. Moreover, increased circulating GrB levels might represent a possible peripheral marker of VAT dysfunction in metabolic diseases.
ISSN: 1664-3224
DOI: 10.3389/fimmu.2020.589188
Appears in Collections:A1. Articolo in rivista

Files in This Item:
File Description SizeFormat Existing users please
fimmu-11-589188.pdf804.89 kBAdobe PDF    Request a copy
Show full item record

Page view(s)

Last Week
Last month
checked on Apr 13, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.